Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Colorectal Neoplasms 136Head and Neck Neoplasms 96Squamous Cell Carcinoma of Head and Neck 89Carcinoma, Non-Small-Cell Lung 58Colonic Neoplasms 44Rectal Neoplasms 38Neoplasm Metastasis 34Neoplasms 28Pancreatic Neoplasms 24Lung Neoplasms 18Carcinoma, Squamous Cell 18Stomach Neoplasms 15Tongue Neoplasms 13Esophageal Neoplasms 13Salivary Gland Neoplasms 11Recurrence 10Breast Neoplasms 10Laryngeal Neoplasms 9Mouth Neoplasms 8Esophageal Squamous Cell Carcinoma 8Carcinoma 8Adenocarcinoma Of Esophagus 8Adenocarcinoma of Lung 7Neoplasms, Squamous Cell 6Hypopharyngeal Neoplasms 6Carcinoma, Renal Cell 6Parkinson Disease 4, Autosomal Dominant Lewy Body 5Oropharyngeal Neoplasms 5Nasopharyngeal Carcinoma 5Carcinoma, Hepatocellular 5

Interventions

pembrolizumab 1nintedanib 1dactolisib 1avelumab 1Vorinostat 1Sunitinib 1Oxaliplatin 1Levoleucovorin 1Leucovorin 1Hydroxychloroquine 1Folfox protocol 1Fluorouracil 1Dasatinib 1DOXO-EMCH 1Cetuximab 1Bevacizumab 1BN 80927 1ARQ 197 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Malignant Solid Tumour × Cetuximab × Clear all
NCT00388427 2015-05-28

Safety Study Of Cetuximab Plus Dasatinib (BMS-354825) in Treating Advanced Solid Malignancies

University of Pittsburgh

Phase 1 Completed
31 enrolled
Other solid neoplasm

Malignant Solid Tumour

Data powered by HemOnc (CC BY 4.0) Colophon âš¡